Page last updated: 2024-08-22

pasiniazide and Tuberculosis, Pulmonary

pasiniazide has been researched along with Tuberculosis, Pulmonary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jiang, Y; Li, G; Li, M; Liu, H; Wan, K; Zhang, J; Zhao, LL; Zhao, X1
Li, SM; Xing, BC; Zheng, XM1
Hu, X; Wang, J; Yu, D1

Trials

2 trial(s) available for pasiniazide and Tuberculosis, Pulmonary

ArticleYear
[Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis].
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:5

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2004
[Clinical research of pasinizid on retreated sputum positive pulmonary tuberculosis in senilities].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2001, Volume: 24, Issue:10

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Radiography; Recurrence; Sputum; Treatment Outcome; Tuberculosis, Pulmonary

2001

Other Studies

1 other study(ies) available for pasiniazide and Tuberculosis, Pulmonary

ArticleYear
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
    Journal of global antimicrobial resistance, 2020, Volume: 20

    Topics: Adult; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Peroxiredoxins; Promoter Regions, Genetic; Repressor Proteins; Tuberculosis, Pulmonary

2020